China Medical Informatization Industry Report,2013-2016
  • Apr./2014
  • Hard Copy
  • USD $1,950
  • Pages:83
  • Single User License
    (PDF Unprintable)       
  • USD $1,850
  • Code: ZLC001
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,850
  • Hard Copy + Single User License
  • USD $2,150
      

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, management information system has been basically established in China's first- and second-class hospitals, where the clinical management information system construction has also got into the late stage, some have embarked on regional healthcare information system.

However, with a shortage supply of funds and resources, most third-class or lower-level Chinese hospitals are still in the construction phase of management information system, and some are only getting started.

According to CHIMA’s sampling survey on 1,067 hospitals nationwide, as of the first half of 2013, hospitals where in-patient nurse workstation system, ward doctor workstation system and out-patient doctor workstation system have been established represent the largest proportion, respectively 69.0%, 59.1% and 51.6%, while those with intensive care information system and clinical decision support system account for the minimum i.e. 13.0% and 14.0%, respectively.

2014040901.png

China's healthcare IT market size grew at a CAGR of 21.7% in 2007-2012, reaching RMB20.6 billion in 2013. According to the NHFPC’s 12th-Five-Year Informatization Promotion Arrangements, China's medical informatization construction carried out in 2012-2013 is principally a gradual “point-to-area” process, followed by a comprehensive promotion in 2014-2015. It is expected that its healthcare IT market size will grow at a CAGR of about 25% in 2013-2016.

With low concentration, there is a small number of cross-regional national healthcare software enterprises in the Chinese medical informatization market, and mainly dominated by domestic-funded enterprises such as Winning Software, Neusoft Group, DHC Software and Tianjian Technology on account of localization issues, early-stage disorderly competition, etc..

However, in the PACS field with a higher degree of standardization, GE, Carestream, Agfa and other foreign companies still occupy important market. Moreover, international IT giants like IBM, NEC, Intel and HP have also penetrated in the Chinese medical informatization market through cooperation with local enterprises, e.g. IBM developed IBM cloud computing architecture-based regional health information solution with Tianjian Technology in 2010; IBM Healthcare Solutions and Yonyou Healthcare jointly set up a laboratory in 2011 and at the same time released Yonyou Healthcare Information platform based on cooperation.

China Medical Informatization Industry Report, 2013-2016 by ResearchinChina focuses on the followings:
20120114.gif??Development environment and relevant policies of China's medical informatization industry;
20120114.gif??Development status, market size, competition pattern, development trend and market size forecast of China's medical informatization industry;
20120114.gif??Operation, development strategy, etc. of 10 key companies in China.

?

1. Overview of Medical Informatization Industry
1.1 Definition
1.2 Classification

2. Status Quo of Global Medical Informatization Industry
2.1 Development History
2.2 Major Countries
2.2.1 USA
2.2.2 UK
2.2.3 Japan
2.2.4 Canada

3. Status Quo of China Medical Informatization Industry
3.1 Development History
3.2 Medical Services
3.2.1 Disproportionate Allocation of Healthcare Resources 
3.2.2 Low Efficiency of Medical Resources
3.2.3 Healthcare Spending
3.3 Relevant Policies
3.4 Status Quo
3.4.1 Medical Informatization Construction
3.4.2 Medical Informatization Project Construction in Various Regions
3.5 Market Size
3.6 Competition Pattern
3.7 Trends
3.7.1 Increase in Market Concentration
3.7.2 Construction of Regional Medical Informatization Platform
3.7.3 Mobile Medical System
3.7.4 IT Giants to Assist Help in Medical Informatization Construction
3.7.5 System Security to Be the Top Concern

4. Key Enterprises
4.1 Winning Software
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D and Investment
4.1.6 Medical Informatization
4.1.7 Forecast and Outlook
4.2 DHC Software
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Medical Informatization
4.2.6 Forecast and Outlook
4.3 Neusoft
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Neusoft Medical
4.4 Wonders Information
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D
4.4.6 Medical Informatization
4.4.7 Forecast and Outlook
4.5 Yonyou Software
4.5.1 Profile
4.5.2 Operation
4.5.3 Gross Margin
4.5.4 Yonyou Healthcare Information System Co., Ltd.
4.5.5 R&D
4.6 Enjoyor
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D and Investment
4.6.6 Medical Informatization
4.6.7 Forecast and Outlook
4.7 YLZ
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R&D and Investment
4.7.6 Medical Informatization
4.7.7 Forecast and Outlook
4.8 Kingdee
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 Kingdee Medical Software Technology Co., Ltd.
4.9 Others
4.9.1 Tianjian Technology 
4.9.2 ZLSOFT

5. Summary and Forecast
5.1 China Healthcare IT Market Size
5.2 Comparison of Business Operation
5.2.1 Revenue
5.2.2 Net Income
5.2.3 Gross Margin
5.2.4 R&D Input
Classification of Medical Informatization
Classification, Function and Subsystem of Medical Informatization in a Narrow Sense
Medical Expenditures in the United States, 1970-2011
Healthcare IT Investment in the United States, 2011-2013
Medical Expenditures in Japan, 1985-2011
Number of Medical and Health Organizations in China, 2012-2013
Number of Beds in Chinese Medical and Health Organizations, 2011-2012
Bed Usage in Chinese Health Authorities, 2012-2013
Amount of Medical Services Offered by Chinese Health Authorities, 2012-2013
Treatment Process in a Chinese Hospital
Medical Informatization Program for Alleviating Difficulty in Seeing Doctor
China’s Health Expenditure Per Capita, 1980-2011
China’s Health Expenditure and % of GDP, 1980-2011
Relevant Policies for Medical Informatization in China, 2006-2013
Construction Vendors and Starting Time for Regional Medical Pilots in China, 2010-2012
Procedures for China’s 12th-Five-Year Medical Informatization Promotion
Status and Target Gap of China’s 12th-Five-Year Medical Informatization Construction, 2012
Status of Hospital Information System Construction in China, 2013H1
Main Obstacles in Chinese Hospital Information Construction, 2013
Developments of Solutions Market for China Medical Informatization Systems, 2010-2015E
Purchase Amount and Project Number of Medical Informatization Procurement around China
China’s Healthcare IT Market Size, 2007-2012
Market Share of Major Medical Solution Providers in China, 2009
Related Business of Major Listed Medical Information Companies in China
Main Product Categories and Sub-products of Winning Software
Revenue and Net Income of Winning Software, 2009-2013
Revenue Structure of Winning Software by Product, 2009-2013 
Revenue Structure of Winning Software by Region, 2009-2013 
Gross Margin of Winning Software, 2009-2013
Gross Margin of Winning Software by Product, 2009-2013 
R&D Costs and % of Total Revenue of Winning Software, 2010-2013
Committed Fund-raising Projects of Winning Software as of 2013
Revenue and Net Income of Winning Software, 2012-2016E 
Revenue and Net Income of DHC Software, 2009-2013  
Revenue Structure of DHC Software by Product, 2009-2013 
Revenue Structure of DHC Software by Sector, 2013
Revenue Structure of DHC Software by Region, 2009-2013
Gross Margin of DHC Software, 2009-2013  
Gross Margin of DHC Software by Sector, 2009-2013 
Gross Margin of DHC Software by Product, 2009-2013
Revenue and Net Income of DHC Software, 2012-2016E 
Revenue and Net Income of Neusoft, 2009-2013 
Revenue Structure of Neusoft by Sector, 2009-2013
Gross Margin of Neusoft Group, 2009-2013
Gross Margin of Neusoft Group by Product, 2009-2013 
Revenue of Neusoft Medical, 2009-2013
Forecast: Revenue of Neusoft Medical, 2012-2016E
Revenue and Net Income of Wonders Information, 2009-2013  
Revenue Structure of Wonders Information by Product, 2009-2013  
Gross Margin of Wonders Information, 2009-2013
Gross Margin of Wonders Information by Product, 2009-2013
R&D Costs and % of Total Revenue of Wonders Information, 2009-2013 
Revenue and Net Income of Wonders Information, 2012-2016
Revenue and Net Income of Yonyou Software, 2009-2013 
Gross Margin of Yonyou Software, 2009-2013H1 
R&D Costs and % of Total Revenue of Yonyou Software, 2011-2013
Revenue and Net Income of Enjoyor, 2009-2013 
Revenue Structure of Enjoyor by Product, 2009-2013
Gross Margin of Enjoyor, 2009-2013H1
Gross Margin of Enjoyor by Product, 2009-2013
R&D Costs and % of Total Revenue of Enjoyor, 2010-2012
Revenue and Net Income of Enjoyor, 2012-2016E 
Revenue and Net Income of YLZ, 2009-2013  
Revenue Structure of YLZ by Product, 2009-2013 
Gross Margin of YLZ, 2009-2013 
Gross Margin of YLZ by Product, 2009-2013 
R&D Costs and % of Total Revenue of YLZ, 2010-2012
Revenue of YLZ, 2012-2016E
Revenue and Net Income of Kingdee, 2009-2013 
Revenue Structure of Kingdee by Product, 2009-2013 
Gross Margin of Kingdee, 2009-2013 
China’s Healthcare IT Market Size, 2012-2016E
Comparison: Revenue of Major Listed Medical Information Companies in China, 2009-2013 
CAGR of Major Listed Medical Information Companies in China, 2009-2012
Comparison: Growth in Annual Revenue of Major Listed Medical Information Companies in China, 2010-2013
Comparison: Net Income of Major Listed Medical Information Companies in China, 2009-2013 
Comparison: Growth in Net Income of Major Listed Medical Information Companies in China, 2010-2013 
Gross Margin of Major Listed Medical Information Companies in China, 2009-2013
R&D Inputs of Major Listed Medical Information Companies in China, 2010-2013
Comparison: R&D Cost as Percentage of Revenue of Major Listed Medical Information Companies in China, 2010-2013

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号